Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma
Neuro Oncol
.
2022 Nov 2;24(11):2005-2007.
doi: 10.1093/neuonc/noac190.
Authors
Diana D Shi
1
,
Gilbert C Youssef
2
,
Amin H Nassar
3
,
Mary Jane Lim-Fat
4
,
Keith L Ligon
5
,
Patrick Y Wen
2
,
Rifaquat Rahman
1
Affiliations
1
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
2
Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
3
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
4
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
5
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
35973053
PMCID:
PMC9629423
DOI:
10.1093/neuonc/noac190
No abstract available
Publication types
Letter
MeSH terms
Brain Neoplasms*
Dacarbazine
Female
Glioblastoma*
Humans
Lymphopenia*
Temozolomide
Substances
Temozolomide
Dacarbazine